Bioavallability of US commercial magnesium preparations

Magnesium Research

Volumn 14, Issue 4, 2001, Pages 257-262

  Firoz, Muhammad ^a   Graber, Mark ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Bioavailability; Hypomagnesemia; Magnesium

Indexed keywords

ASPARTIC ACID; MAGNESIUM CHLORIDE; MAGNESIUM DERIVATIVE; MAGNESIUM OXIDE;

ADULT; ARTICLE; BIOAVAILABILITY; COMPARATIVE STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; MIDDLE AGED; UNITED STATES;

ADULT; ASPARTIC ACID; BIOLOGICAL AVAILABILITY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MAGNESIUM CHLORIDE; MAGNESIUM COMPOUNDS; MAGNESIUM OXIDE; MALE; MIDDLE AGED; UNITED STATES;

EID: 0035748332     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Whang, R. (1997): Clinical disorders of magnesium metabolism. Compr. Ther. 23: 168-173.
2. Kobrin, S. M. & Goldfarb, S. (1990): Magnesium deficiency. Semin. Nephrol. 10: 525-535.
3. Liao, F., Folsom, A. R. & Brancali, F. L. (1998): Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis in Communities (ARIC) Study. Am. Heart. J. 136: 480-490.
4. Whang, R. & Ryder, K. W. (1990): Frequency of hypomagnesemia and hypermagnesemia. JAMA 263: 3063-3064.
5. Dipalma, J. R. (1990): Magnesium replacement therapy. Am. Fam. Physician 42: 173-176.
6. Oster, J. R. & Epstein, M. (1998): Management of magnesium depletion. Am. J. Nephrol. 8: 349-354.
7. Fine, K. D., Santa Ana, C. A., Porter J. L. & Fordtran, J. S. (1991): Intestinal absorption of magnesium from food and supplements. J. Clin. Invest. 88: 396-402.
8. Hardwick, L. L., Jones, M.R., Brautbar, N. & Lee. D. B. N. (1991): Magnesium absorption: Mechanisms and the influence of vitamin D, calcium, and phosphate. J. Nutr 121: 13-23.
9. Schweigel, M. & Martens, H. (2000): Magnesium transport in the gastrointestinal tract. Front. Biosci. 5: D666-77.
10. Morris, M. E., LeRoy & Sutton, S. C. (1987): Absorption of magnesium from orally administered magnesium sulfate in man. Clin. Toxicol. 25: 371-382.
11. Benech, H. & Grognet, J. M. (1995): Recent data on the evaluation of magnesium bioavailability in humans. Magnes. Res. 8: 277-284.
12. Lindberg, J. S., Margaret, M., Zobitz, M., Poindexler, J. R. & Pak C. Y. C. (1990): Magnesium bioavailability from magnesium citrate and magnesium oxide. J. Am. Coll. Nutr. 9: 48-55.
13. Kuhn, I., Jost, V., Wleckhorst, G., Thei, U. & Lucker, P. W. (1992): Renal elimination of magnesium as a parameter of bioavailability of oral magnesium therapy. Meth. Find. Exp. Clin. Pharmacol. 14: 269-272.
14. Bøhmer, T., Røseth, A., Holm, H., Weberg-Teigen, S. & Wahl, L. (1990): Bioavailability of oral magnesium supplementation in female students evaluated from elimination of magnesium in 24-hour urine. Magnes. Trace Elem. 9: 272-278.
15. Abrams, S. A. & Wen, J. P. (1999): Methodologies for using stable isotopes to assess magnesium absorption and secretion in children. J. Am. Coll. Nutr. 18: 30-5.
16. Golf, S. W. Riediger, H., Matthes, S., Kuhn, D., Graef, V., Temme, H., Katz, N. & Roka, L. (1990): Homeostasis of magnesium in man after oral supplementation: Results of a placebo controlled blind study. Magnes. Bull. 12: 144-148.
17. 28Mg in man. Metabolism 9: 647-659.
18. Fetner, C. D., Barilla, D. E., Townsend, J. & Pak, C. Y. C. (1978): Effect of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis. J. Urol. 120: 399-401.
19. Speich, M. & Bousquet, B. (1991): Magnesium: Recent data on metabolism, exploration pathology and theraeutics. Magnes. Bull. 13: 116-121.
20. Mühlbauer, B., Schwenk, M., Coram, W. M., Antonin, K. H., Etienne, P., Bieck, P. R. & Douglas, F. L. (1991): Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers. Eur. J. Clin. Pharmacol. 40: 437-438.